CNMD - CONMED - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNMD is currently covered by 9 analysts with an average price target of $88.56. This is a potential upside of $16.8 (23.41%) from yesterday's end of day stock price of $71.76.

CONMED's activity chart (see below) currently has 96 price targets and 92 ratings on display. The stock rating distribution of CNMD is 86.49% BUY and 13.51% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.74% with an average time for these price targets to be met of 167 days.

Highest price target for CNMD is $141, Lowest price target is $75, average price target is $88.56.

Most recent stock forecast was given by ROBBIE MARCUS from JPMORGAN on 25-Apr-2024. First documented stock forecast 16-Jan-2015.

Currently out of the existing stock ratings of CNMD, 32 are a BUY (86.49%), 5 are a HOLD (13.51%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

75

$3.24 (4.52%)

115

9 days ago

2/6 (33.33%)

$13.1 (21.16%)

268

Buy

129

$57.24 (79.77%)

119

3 months 3 days ago

22/29 (75.86%)

$45.24 (54.01%)

219

Buy

100

$28.24 (39.35%)

130

3 months 3 days ago

15/19 (78.95%)

$16.24 (19.39%)

217

Hold

98

$26.24 (36.57%)

107

3 months 3 days ago

2/3 (66.67%)

$14.24 (17.00%)

20

Buy

120

$48.24 (67.22%)

136

6 months 8 days ago

10/13 (76.92%)

$25.78 (27.36%)

178

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CNMD (CONMED) average time for price targets to be met?

On average it took 167 days on average for the stock forecasts to be realized with a an average price target met ratio 66.74

Which analyst has the current highest performing score on CNMD (CONMED) with a proven track record?

MATT O'BRIEN

Which analyst has the most public recommendations on CNMD (CONMED)?

Matt O'brien works at PIPER SANDLER and has 14 price targets and 10 ratings on CNMD

Which analyst is the currently most bullish on CNMD (CONMED)?

Matthew Mishan with highest potential upside - $69.24

Which analyst is the currently most reserved on CNMD (CONMED)?

Matthew Taylor with lowest potential downside - -$15.85

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?